GL1X · GenesisL1 explorer

MolNFT v1 · #104853 · protein

Crystal structure of neuramnidase N7 complexed with oseltamivir

4QN7 · Neuraminidase: “Crystal structure of neuramnidase N7 complexed with oseltamivir”. X-ray diffraction, 4 ligands (G39, NAG, BMA), 5 pockets (best druggability 0.78). MolNFT v1 #104853 on GenesisL1: 3D structure, binding sites and…

PDB
4QN7
Type
protein
Length
780 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Neuraminidase
UniProt
Q20R18
Ligands
G39, NAG, BMA, CA
Pockets
5 · best druggability 0.78

Structure

x-ray diffraction · 1 distinct chain · 4% helix, 45% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
A, BNeuraminidaseprotein3904% helix, 45% strandQ20R18

Ligands and binding sites

  • G39 · (3R,4R,5S)-4-(acetylamino)-5-amino-3-(pentan-3-yloxy) cyclohex-1-ene-1-carboxylic acid · ligand · 2 copies · chains A, B
  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 10 copies · chains A, B
  • BMA · beta-D-mannopyranose · sugar · 2 copies
  • CA · Calcium ion · metal · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

5 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111110.780.80100G39
22770.620.8042G39
3520.330.7815empty
4670.320.7615empty
5560.320.7719empty

Interfaces

1 interface between chains.

  • A–B · 150 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 18 disulfide, 6 glycan (disulfide, N-glycosylation).

Compared structures

  • 4QN7 · Crystal structure of neuramnidase N7 complexed with Oseltamivir · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.